lobbying_activities: 1515847

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1515847	f07a4467-26aa-4dd8-9654-5da12c3c8ebb	Q1	VENABLE LLP	39941	ENDO PHARMACEUTICALS INC	2014	first_quarter	PHA	Issues related to bioequivalence and related administrative procedures; issues related to prescription drug abuse; issues related to the labeling of generic drugs.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2014-04-14T18:23:07.950000-04:00